$EXASGreen: Entry Point
Blue: Start of Week
Red: End of Week
Thumbs Up: Trade Available for Week
Numbers: Price Targets
*For share traders only. Not meant for options.
−0.001 BRL
−1.02 B BRL
12.49 B BRL
About Exact Sciences Corporation
Sector
Industry
CEO
Kevin T. Conroy
Website
Headquarters
Madison
Founded
1995
ISIN
BRE2XABDR009
FIGI
BBG014XJFNW0
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.
EXAS a Bullish OutlookAs I predicted before, I had a 100% success rate. Let's consider a long position based on the current technical indicators.
Trend Line: We have a yellow trend line where the price bounced in 2016 and 2022. We are now approaching this trend line again.
Bat Pattern: The bat pattern indicates that poi
Exact Sciences: Anticipating a Market Correction Amidst OverbougExact Sciences is exhibiting bullish tendencies at present, but it's critical to anticipate a substantial correction upon touching, or descending below, the 0.618 Fibonacci retracement level. The stock is likely to retreat to around $70, a significant support level we've observed. The patterns in pl
Exact Sciences (EXAS) - Continuation of the DowntrendBased on my previous technical analysis where Exact Sciences exhibited bullish tendencies but warned of a possible substantial correction around the $70 level, we now find ourselves at a critical junction. Two possible scenarios could unfold from here: a bearish three drives pattern leading to a bou
ABC Correction looks to be over for EXASCorrection could now be over @ 62% retrace.
Looking for a move up to the upper trend line into 2027 based on previous cycles.
+ Momentum divergence at the c wave low suggests energy is building for the next move higher.
Trendchanges and its author are not registered financial advisors. Every
Exact Sciences Corporation Fundamentally The Company have a really good quarterly results and is looking cheap at this price. Technically we can see buying pressure from good area of support. Price might go as high as 84.50/85.50 $ before next quarterly results.
EXAS - Amazing symmetry
If you want to know where price is going to be, look for the history. Will this break out of this range and head higher or flush below?
if it can close above 65 this week, I would keep an eye on it above 68. It moves quickly so a news could push this over/under.
Long via commons and optio
Exact sciences corp Exact Sciences is a biotech stock that is overpriced.
It's time to sell
We touched 3 times the resistance line of a rising wedge pattern, impulsive wave pattern, and RSI 71 weekly overbought zone, the Q2 doesn't seem good.
A leg down to 60$ retesting 69$ which is the resistance line of a rising
Long Trade in EXASExact Sciences is a biotech stock showing high relative strength.
Following a 50% jump in January, the stock is tightening with pullbacks getting shallower from left to right.
This is a sign of seller digestion which we often see before a new breakout to the upside.
EXAS is also finding support a
$EXAS Setting UpI am not looking to take any more risk tomorrow but $EXAS is setting up an early turn low risk entry.
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
EXAS4586328
Exact Sciences Corporation 1.0% 15-JAN-2025Yield to maturity
5.75%
Maturity date
Jan 15, 2025
EXAS4957195
Exact Sciences Corporation 0.375% 01-MAR-2028Yield to maturity
4.20%
Maturity date
Mar 1, 2028
EXAS4806408
Exact Sciences Corporation 0.375% 15-MAR-2027Yield to maturity
3.92%
Maturity date
Mar 15, 2027
EXAS5793007
Exact Sciences Corporation 1.75% 15-APR-2031Yield to maturity
3.80%
Maturity date
Apr 15, 2031
EXAS5549793
Exact Sciences Corporation 2.0% 01-MAR-2030Yield to maturity
2.65%
Maturity date
Mar 1, 2030
Explore more bonds
Curated watchlists where E2XA34 is featured.
